Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
Merus(MRUS) Newsfilter·2024-07-01 12:00"I am pleased to welcome Fabian Zohren to Merus as our new CMO and confident that his proven clinical development skills and late stage registrational trial experience will prove invaluable as we plan to initiate two phase 3 trials in 2024 for petosemtamab, and continue to build out a development strategy that maximizes the opportunity this important clinical candidate may have for patients," said Bill Lundberg, M.D., President, Chief Executive Officer of Merus. "I am grateful for Andrew's leadership partic ...